Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Pinotti

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Haematologica|December 14, 2004
Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s)Christian Furlan Freguia, Raffaella Toso, Eleanor S Pollak, et al.
Blood|June 24, 2010
The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulationCaterina Casari, Mirko Pinotti, Stefano Lancellotti, et al.
Haematologica|December 23, 2003
The Gly331Ser mutation in factor VII in Europe and the Middle EastDaniela Etro, Mirko Pinotti, Karin Wulff, et al.
Plos Genetics|May 27, 2016
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein FunctionMojca Tajnik, Malgorzata Ewa Rogalska, Erica Bussani, et al.
Molecular Therapy. Nucleic Acids|October 5, 2016
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing MutantsDario Balestra, Daniela Scalet, Franco Pagani, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 22, 2019
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contextsSilvia Pignani, Federico Zappaterra, Elena Barbon, et al.
Journal of Human Genetics|March 3, 2018
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correctionDaniela Scalet, Claudia Sacchetto, Francesco Bernardi, et al.
International Journal of Molecular Sciences|February 25, 2023
Counteracting the Common Shwachman-Diamond Syndrome-Causing <i>SBDS</i> c.258+2T>C Mutation by RNA Therapeutics and Base/Prime EditingLaura Peretto, Elena Tonetto, Iva Maestri, et al.
Biochimica Et Biophysica Acta|August 19, 2007
Characterization of anti-coagulant properties of prenylated coumarin ferulenolMonia Monti, Mirko Pinotti, Giovanni Appendino, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 6, 2003
Modulation of factor V levels in plasma by polymorphisms in the C2 domainDaniela Scanavini, Domenico Girelli, Barbara Lunghi, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Haematologica|December 14, 2004
Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s)Christian Furlan Freguia, Raffaella Toso, Eleanor S Pollak, et al.
Blood|June 24, 2010
The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulationCaterina Casari, Mirko Pinotti, Stefano Lancellotti, et al.
Haematologica|December 23, 2003
The Gly331Ser mutation in factor VII in Europe and the Middle EastDaniela Etro, Mirko Pinotti, Karin Wulff, et al.
Plos Genetics|May 27, 2016
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein FunctionMojca Tajnik, Malgorzata Ewa Rogalska, Erica Bussani, et al.
Molecular Therapy. Nucleic Acids|October 5, 2016
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing MutantsDario Balestra, Daniela Scalet, Franco Pagani, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 22, 2019
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contextsSilvia Pignani, Federico Zappaterra, Elena Barbon, et al.
Journal of Human Genetics|March 3, 2018
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correctionDaniela Scalet, Claudia Sacchetto, Francesco Bernardi, et al.
International Journal of Molecular Sciences|February 25, 2023
Counteracting the Common Shwachman-Diamond Syndrome-Causing <i>SBDS</i> c.258+2T>C Mutation by RNA Therapeutics and Base/Prime EditingLaura Peretto, Elena Tonetto, Iva Maestri, et al.
Biochimica Et Biophysica Acta|August 19, 2007
Characterization of anti-coagulant properties of prenylated coumarin ferulenolMonia Monti, Mirko Pinotti, Giovanni Appendino, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 6, 2003
Modulation of factor V levels in plasma by polymorphisms in the C2 domainDaniela Scanavini, Domenico Girelli, Barbara Lunghi, et al.
Pageof 10